ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "4f9fcce7-29ee-468d-9b91-4ec50f64fdf6"}, "_deposit": {"id": "23494", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "23494"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00023494", "sets": ["456", "1222"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "H_2-receptor Antagonist Therapy : With Special Reference to Ranitidine(Current Medical Therapy for Upper Gastrointestinal Ulcer Disease)"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1988-05", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "5", "bibliographicPageEnd": "261", "bibliographicPageStart": "255", "bibliographicVolumeNumber": "102", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The cure rate for endoscopic therapy was determined in 61 patients with a gastroduodenal ulcer who received Ranitidine at a dose of 150 mg twice daily, in the morning and evening. The ulcer patients were classified into initial-, recurrent-and intractable-ulcer groups, and the cumulative cure rate was compared among the three types of ulcers. The cure rate was 93% for the initial ulcer, 78% for recurrent and 50% for intractable. Uncured ulcers accounted for about 10% of the patients, and the rate of uncured ulcers was particularly high among duodenal ulcer patients. The patients\u0027 background factors such as smoking or nonsmoking, seasonal variation, and blood type were also compared among the three groups of patients. Specific endoscopic findings which were studied after use of an H_2-blocker were characterized by an elevation of the mucous membrane around the ulcer. The effects of H_2-blocker dosage reduction and discontinuation on gastroduodenal were determined. Given the fact that all patients relapsed after discontinuation of the H_2-blocker, ulcers seem to indicate maintenance H_2-blocker therapy, and smoking patients, among others, appear to be in need of lifetime therapy. When using an H_2-blocker, its indication should be clearly determined, and therapy should be instituted in due consideration of an ulcer as a psychosomatic disorder.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "141407", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Watanabe, Yutaka"}]}, {"nameIdentifiers": [{"nameIdentifier": "141408", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Murayama, Hisao"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "渡辺, 裕"}], "nameIdentifiers": [{"nameIdentifier": "141405", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "村山, 久夫"}], "nameIdentifiers": [{"nameIdentifier": "141406", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-19"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "102(5)_255-261.pdf", "filesize": [{"value": "1.8 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1800000.0, "url": {"label": "102(5)_255-261.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/23494/files/102(5)_255-261.pdf"}, "version_id": "e94f9f24-2db1-49ce-abdd-5af469e37420"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "ranitidine", "subitem_subject_scheme": "Other"}, {"subitem_subject": "cumulative cure rate", "subitem_subject_scheme": "Other"}, {"subitem_subject": "H_2-blocker", "subitem_subject_scheme": "Other"}, {"subitem_subject": "specific endoscopic findings", "subitem_subject_scheme": "Other"}, {"subitem_subject": "maintenance therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "ラニチジン", "subitem_subject_scheme": "Other"}, {"subitem_subject": "累積治癒率", "subitem_subject_scheme": "Other"}, {"subitem_subject": "H_2-受容体拮抗剤", "subitem_subject_scheme": "Other"}, {"subitem_subject": "特異的内視鏡像", "subitem_subject_scheme": "Other"}, {"subitem_subject": "維持療法", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "3) H_2-受容体拮抗薬による治療 : ラニチジンを中心に(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "3) H_2-受容体拮抗薬による治療 : ラニチジンを中心に(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)"}, {"subitem_title": "3) H_2-受容体拮抗薬による治療 : ラニチジンを中心に(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1222"], "permalink_uri": "http://hdl.handle.net/10191/40758", "pubdate": {"attribute_name": "公開日", "attribute_value": "2016-04-05"}, "publish_date": "2016-04-05", "publish_status": "0", "recid": "23494", "relation": {}, "relation_version_is_last": true, "title": ["3) H_2-受容体拮抗薬による治療 : ラニチジンを中心に(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)"], "weko_shared_id": null}
  1. 0 資料タイプ別
  2. 03 紀要論文
  1. 250 大学院医歯学総合研究科(医)
  2. 20 紀要
  3. 02 新潟医学会雑誌
  4. 第102巻第5号

3) H_2-受容体拮抗薬による治療 : ラニチジンを中心に(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)

http://hdl.handle.net/10191/40758
http://hdl.handle.net/10191/40758
d6dc9bde-c269-49f3-9844-aca50b4524d1
名前 / ファイル ライセンス アクション
102(5)_255-261.pdf 102(5)_255-261.pdf (1.8 MB)
Item type 紀要論文 / Departmental Bulletin Paper(1)
公開日 2016-04-05
タイトル
タイトル 3) H_2-受容体拮抗薬による治療 : ラニチジンを中心に(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)
タイトル
言語 en
タイトル 3) H_2-受容体拮抗薬による治療 : ラニチジンを中心に(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)
言語
言語 jpn
キーワード
主題Scheme Other
主題 ranitidine
キーワード
主題Scheme Other
主題 cumulative cure rate
キーワード
主題Scheme Other
主題 H_2-blocker
キーワード
主題Scheme Other
主題 specific endoscopic findings
キーワード
主題Scheme Other
主題 maintenance therapy
キーワード
主題Scheme Other
主題 ラニチジン
キーワード
主題Scheme Other
主題 累積治癒率
キーワード
主題Scheme Other
主題 H_2-受容体拮抗剤
キーワード
主題Scheme Other
主題 特異的内視鏡像
キーワード
主題Scheme Other
主題 維持療法
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ departmental bulletin paper
その他のタイトル
その他のタイトル H_2-receptor Antagonist Therapy : With Special Reference to Ranitidine(Current Medical Therapy for Upper Gastrointestinal Ulcer Disease)
著者 渡辺, 裕

× 渡辺, 裕

WEKO 141405

渡辺, 裕

Search repository
村山, 久夫

× 村山, 久夫

WEKO 141406

村山, 久夫

Search repository
著者別名
識別子 141407
識別子Scheme WEKO
姓名 Watanabe, Yutaka
著者別名
識別子 141408
識別子Scheme WEKO
姓名 Murayama, Hisao
抄録
内容記述タイプ Abstract
内容記述 The cure rate for endoscopic therapy was determined in 61 patients with a gastroduodenal ulcer who received Ranitidine at a dose of 150 mg twice daily, in the morning and evening. The ulcer patients were classified into initial-, recurrent-and intractable-ulcer groups, and the cumulative cure rate was compared among the three types of ulcers. The cure rate was 93% for the initial ulcer, 78% for recurrent and 50% for intractable. Uncured ulcers accounted for about 10% of the patients, and the rate of uncured ulcers was particularly high among duodenal ulcer patients. The patients' background factors such as smoking or nonsmoking, seasonal variation, and blood type were also compared among the three groups of patients. Specific endoscopic findings which were studied after use of an H_2-blocker were characterized by an elevation of the mucous membrane around the ulcer. The effects of H_2-blocker dosage reduction and discontinuation on gastroduodenal were determined. Given the fact that all patients relapsed after discontinuation of the H_2-blocker, ulcers seem to indicate maintenance H_2-blocker therapy, and smoking patients, among others, appear to be in need of lifetime therapy. When using an H_2-blocker, its indication should be clearly determined, and therapy should be instituted in due consideration of an ulcer as a psychosomatic disorder.
書誌情報 新潟医学会雑誌
en : 新潟医学会雑誌

巻 102, 号 5, p. 255-261, 発行日 1988-05
出版者
出版者 新潟医学会
ISSN
収録物識別子タイプ ISSN
収録物識別子 00290440
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AN00182415
著者版フラグ
値 publisher
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 12:54:02.810307
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3